When.com Web Search

  1. Ads

    related to: oesophagus adenocarcinoma treatment

Search results

  1. Results From The WOW.Com Content Network
  2. Esophageal cancer - Wikipedia

    en.wikipedia.org/wiki/Esophageal_cancer

    Esophageal cancer is cancer arising from the esophagus —the food pipe that runs between the throat and the stomach. [2] Symptoms often include difficulty in swallowing and weight loss. [1] Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a dry cough, and possibly coughing ...

  3. Oesophagogastric junctional adenocarcinoma - Wikipedia

    en.wikipedia.org/wiki/Oesophagogastric_junction...

    Oesophagogastric junctional adenocarcinoma. Oesophagogastric junctional adenocarcinoma (OGJ adenocarcinoma) is a cancer of the lower part of the oesophagus with a rising incidence in Western countries. [1] This disease is often linked to Barrett's oesophagus. The incidence of OGJ adenocarcinoma is rising rapidly in Western countries especially ...

  4. US FDA approves BeiGene's esophageal cancer therapy - AOL

    www.aol.com/news/us-fda-approves-beigenes...

    The therapy, branded as Tevimbra, was approved as a monotherapy for adult patients with unresectable or metastatic esophageal squamous cell carcinoma. The American Cancer Society estimates there ...

  5. Barrett's esophagus - Wikipedia

    en.wikipedia.org/wiki/Barrett's_esophagus

    Nausea. Barrett's esophagus is a condition in which there is an abnormal (metaplastic) change in the mucosal cells lining the lower portion of the esophagus, from stratified squamous epithelium to simple columnar epithelium with interspersed goblet cells that are normally present only in the small intestine and large intestine.

  6. Ramucirumab - Wikipedia

    en.wikipedia.org/wiki/Ramucirumab

    Ramucirumab is a direct VEGFR2 antagonist, that binds with high affinity to the extracellular domain of VEGFR2 and block the binding of natural VEGFR ligands (VEGF-A, VEGF-C and VEGF-D). These ligands are secreted by solid tumors to promote angiogenesis (formation of new blood vessels from pre-existing ones) and enhance tumor blood supply.

  7. Gastrointestinal cancer - Wikipedia

    en.wikipedia.org/wiki/Gastrointestinal_cancer

    Barrett's esophagus is the dominant pre-malignant lesion of esophageal adenocarcinoma, [18] and has prevalent epigenetic alterations. [19] Esophageal squamous-cell carcinomas may occur as second primary tumors associated with head and neck cancer, due to field cancerization (i.e. a regional reaction to long-term carcinogenic exposure).

  1. Ads

    related to: oesophagus adenocarcinoma treatment